Tyrosine kinase inhibitors

Details Tyrosine kinase inhibitors Tyrosine kinase inhibitors

2011-08-30

2011-08-30

Chu, Yong (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S317000, C514S415000, C514S419000

Reexamination Certificate

active

08008295

ABSTRACT:
The present invention relates to compounds that are capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases. The compounds of the instant invention possess a core structure that comprises an indole-sulfonamide moiety. The present invention is also related to the pharmaceutically acceptable salts, hydrates and stereoisomers of these compounds.

REFERENCES:
patent: 3180875 (1965-04-01), Szmuszkovicz et al.
patent: 5527819 (1996-06-01), Williams et al.
patent: 5962490 (1999-10-01), Chan et al.
patent: 2005/0261496 (2005-11-01), Dinsmore et al.
patent: 0070698 (1985-11-01), None
patent: 1410699 (1965-08-01), None
patent: WO96/31492 (1996-10-01), None
patent: WO98/50356 (1998-11-01), None
patent: WO03/035621 (2003-05-01), None
Gohji et al., The Journal of Urology, vol. 165 (3), p. 1033-1036, published Mar. 2001 (Abstract).
STN—12605690A—kinase—Nov. 16, 2010.
Szmuszkovicz, J., et al. Journal of Organic Chemistry, American Chemical Society, vol. 29, pp. 178-184 (1964).
Arteaga, C. L. et al., J. Clin. Invest, vol. 84, pp. 1418-1423 (1989).
Baserga, R., Trends in Biotechnology (Tibtech), vol. 14, pp. 150-152 (1996).
Baserga, R., Cell, vol. 79, pp. 927-930 (1994).
Baserga, R., Cancer Research, vol. 55, pp. 249-252 (1995).
Bolen, J. B. et al., The FASEB Journal, vol. 6, pp. 3403-3409 (1992).
Cance, W. G., et al., Int. J. Cancer, vol. 54, pp. 571-577 (1993).
Coppola, D., et al., Molecular and Cellular Biology, vol. 14, pp. 4588-4595 (1994).
Goldring, M. B., et al., Eukaryotic Gene Expression, vol. 1, pp. 301-326 (1991).
Kenyon, C., et al., Cell, vol. 105, pp. 165-168 (2001).
Khandwala, H. M., et al., Endocrine Reviews, vol. 21, pp. 215-244 (2000).
Kimura, K. D., et al., Science, vol. 277, pp. 942-946 (1997).
MacAulay, V. M., et al., Cancer Research, vol. 50, pp. 2511-2517 (1990).
Minet, et al., International Journal of Molecular Medicine, vol. 5, pp. 253-259 (2000).
Plowman, G. E., et al., DN&P, vol. 7, pp. 334-339 (1994).
Sandberg-Nordqvist, A. C., et al., Cancer Research, vol. 53, pp. 2475-2478 (1993).
Scalia, P., et al., Journal of Cellular Biochemistry, vol. 82, pp. 610-618 (2001).
Sepp-Lorenzino, L., et al., J. Cell Biochem. Suppl., vol. 18b, pp. 246 (1994).
Smith, L. E., et al., Nature Medicine, vol. 5, pp. 1390-1395 (1999).
Strauss, E., Science, vol. 292, pp. 41-43 (2001).
Tatar, M. et al., Science, vol. 292, pp. 107-110 (2001).
Zhang, L., et al., Science, vol. 276, pp. 1268-1272 (1997).
STN Search Report, Szmuszkovicz, US Patent 3,180,875, (2009).
U.S. Appl. No. 10/523,286 Office Action mailed on Jun. 21, 2006.
U.S. Appl. No. 10/523,286 Office Action mailed on Nov. 8, 2006.
U.S. Appl. No. 10/523,286 Office Action mailed on Jun. 11, 2007.
U.S. Appl. No. 10/523,285 Office Action mailed on Oct. 15, 2007.
U.S. Appl. No. 10/523,285 Office Action mailed on Apr. 11, 2008.
U.S. Appl. No. 10/523,285 Office Action mailed on Aug. 14, 2008.
Beshore, et al., Synthetic Communications, vol. 33 (14), pp. 2423-2427 (2003).
Blaikie, et al., J. of Biol. Chem., vol. 269 (51), pp. 32031-32034 (1994).
Bolen, et al., Oncogene, vol. 8, pp. 2025-2031 (1993).
Cullen, K.J. et al., Cancer Investigation, vol. 9 (4), pp. 443-454 (1991).
Fantl, W.J. et al., Cell, vol. 69, pp. 413-423 (1992).
Gustafson, T.A. et al., Molecular and Cellular Biology, vol. 15, No. 5, pp. 2500-2508 (1995).
Kavanaugh, W.M. et al., Science, vol. 266, pp. 1862-1865 (1994).
Koch, C.A. et al., Science, vol. 252, pp. 668-674 (1991).
Krywicki, R.F. et al., Breast Cancer Research and Treatment, vol. 22, pp. 7-19 (1992).
Schlessinger, J. et al., Neuron, vol. 9, pp. 383-391 (1992).
Schmid, C., Journal of Internal Medicine, vol. 243, pp. 535-542 (1993).
Songyang, Z. et al., Molecular and Cellular Biology, vol. 14, No. 4, pp. 2777-2785 (1994).
Songyang, Z. et al., Cell, vol. 72, pp. 767-778 (1993).
Velaparthi, et al., Bioorg. Med. Chem. Lett., vol. 17, pp. 2317-2321 (2007).
Matsuno, et al., J. Med. Chem., vol. 45, pp. 3057-3066 (2002).
Traxler, Exp. Opin. Ther. Patents, vol. 7(6), pp. 571-588, XP002122590 (1997).
U.S. Appl. No. 11/890,755 Office Action mailed on Jul. 24, 2009.

Affiliated with

Also associated with

Rating

Tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tyrosine kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2661839